Related Experiment Video
Updated: Dec 10, 2025

10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
4.0K
Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid
Manjot K Grewal1,2, Shruti Chandra1,2, Sarega Gurudas1
1Institute of Ophthalmology, University College London, London EC1V9EL, UK.
Journal of Clinical Medicine
|September 5, 2020
Summary
Subretinal drusenoid deposits (SDD) impact visual function in age-related macular degeneration (AMD). While low luminance deficit (LLD) isn't a disease severity marker, visual acuity tests show SDD affects vision, especially with geographic atrophy.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vision Science
Background:
- Age-related macular degeneration (AMD) classification is evolving.
- Subretinal drusenoid deposits (SDD) are increasingly recognized in AMD.
- Understanding SDD's impact on visual function is crucial.
Purpose of the Study:
- To evaluate visual acuity and perceived visual function with SDD in AMD classification.
- To compare visual function tests across different AMD stages including SDD.
- To determine the utility of low luminance deficit (LLD) and low luminance questionnaire (LLQ) in assessing SDD impact.
Main Methods:
- Recruited 50 participants across healthy aging, intermediate AMD (with/without SDD), and atrophic AMD groups.
- Measured best-corrected visual acuity (BCVA) and low luminance visual acuity (LLVA).
- Calculated LLD and administered the LLQ; analyzed data using linear regression.
Main Results:
- BCVA and LLVA were reduced in atrophic AMD and in patients with SDD compared to healthy controls.
- Atrophic AMD patients showed reduced BCVA and LLVA versus intermediate AMD without SDD.
- LLD did not differ between groups; LLQ correlated with current AMD classification but not SDD presence.
Conclusions:
- LLD is not a reliable clinical marker for AMD disease severity.
- The LLQ reflects general AMD severity but doesn't distinguish SDD presence.
- Eyes with geographic atrophy and SDD exhibit poorer visual function than those without SDD and healthy controls.

